Search research articles
Contact Us
Filters
Showing results (231-240 of 243) with videos related to
Page
of 25
Sort By:
Arthritis and Rheumatism
|
October 19, 2000
Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups
A W Morgan, B Griffiths, F Ponchel, et al.
Annals of the Rheumatic Diseases
|
February 15, 2005
Analysis of the insertion/deletion related polymorphism within T cell antigen receptor beta variable genes in primary Sjögren's syndrome
C A Lawson, I J Donaldson, S J Bowman, et al.
Oncogene
|
July 1, 2026
Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
S Ros, J Flöter, I Kaymak, et al.
Oncogene
|
January 17, 2017
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
S Ros, J Flöter, I Kaymak, et al.
Annals of the Rheumatic Diseases
|
April 15, 2004
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis
C-S Yee, C Gordon, C Dostal, et al.
Annals of the Rheumatic Diseases
|
May 24, 2007
BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000
C-S Yee, D A Isenberg, A Prabu, et al.
Applied Microbiology and Biotechnology
|
October 26, 1999
An integrated strategy for the process development of a recombinant antibody-cytokine fusion protein expressed in BHK cells
C Burger, M J Carrondo, H Cruz, et al.
BJS Open
|
April 11, 2021
A systematic review of outcome reporting in incisional hernia surgery
D Harji, C Thomas, S A Antoniou, et al.
Rheumatology (Oxford, England)
|
April 9, 2005
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
D A Isenberg, A Rahman, E Allen, et al.
Arthritis and Rheumatism
|
August 16, 2000
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone
S M Proudman, P G Conaghan, C Richardson, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 243) with videos related to
Sort By:
Page
of 25
Arthritis and Rheumatism
|
October 19, 2000
Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups
A W Morgan, B Griffiths, F Ponchel, et al.
Annals of the Rheumatic Diseases
|
February 15, 2005
Analysis of the insertion/deletion related polymorphism within T cell antigen receptor beta variable genes in primary Sjögren's syndrome
C A Lawson, I J Donaldson, S J Bowman, et al.
Oncogene
|
July 1, 2026
Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
S Ros, J Flöter, I Kaymak, et al.
Oncogene
|
January 17, 2017
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
S Ros, J Flöter, I Kaymak, et al.
Annals of the Rheumatic Diseases
|
April 15, 2004
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis
C-S Yee, C Gordon, C Dostal, et al.
Annals of the Rheumatic Diseases
|
May 24, 2007
BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000
C-S Yee, D A Isenberg, A Prabu, et al.
Applied Microbiology and Biotechnology
|
October 26, 1999
An integrated strategy for the process development of a recombinant antibody-cytokine fusion protein expressed in BHK cells
C Burger, M J Carrondo, H Cruz, et al.
BJS Open
|
April 11, 2021
A systematic review of outcome reporting in incisional hernia surgery
D Harji, C Thomas, S A Antoniou, et al.
Rheumatology (Oxford, England)
|
April 9, 2005
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
D A Isenberg, A Rahman, E Allen, et al.
Arthritis and Rheumatism
|
August 16, 2000
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone
S M Proudman, P G Conaghan, C Richardson, et al.
Page
of 25